Early research (Phase 1)Ended earlyNCT03936959What this trial is testingLY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 10
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Early research (Phase 1)Looking for participantsNCT07181369What this trial is testingGTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaWho this might be right forHealthy SubjectsCold UrticariaSymptomatic Dermographism+1 more Granular Therapeutics Limited 72
Testing effectiveness (Phase 2)Study completedNCT01221675What this trial is testingTF2- Small Cell Lung Cancer Radio ImmunotherapyWho this might be right forSmall Cell Lung CancerCEA-expressing Non Small Cell Lung Carcinoma (NSCLC) Centre René Gauducheau 18
Testing effectiveness (Phase 2)Looking for participantsNCT06976476What this trial is testingStudy of IgPro20 to Prevent Infection in People With Multiple Myeloma and HypogammaglobulinemiaWho this might be right forMultiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired Memorial Sloan Kettering Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT04868708What this trial is testingAK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Akeso 50
Early research (Phase 1)Looking for participantsNCT06835140What this trial is testingCD123-CD16-NK Cells Immunotherapy for AMLWho this might be right forAML (Acute Myelogenous Leukemia)NK CellCD123+ Acute Myeloid Leukemia Chunji Gao 9
Testing effectiveness (Phase 2)Looking for participantsNCT06925724What this trial is testingIvonescimab in People With Endometrial and Cervical CancersWho this might be right forEndometrial CancerCervical Cancer Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)Looking for participantsNCT07195916What this trial is testingEvaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesWho this might be right forSolid TumorsHematologic Malignancies Incyte Corporation 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902What this trial is testingIvonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma (NPC) Sun Yat-sen University 48
Testing effectiveness (Phase 2)Study completedNCT01741792What this trial is testingClinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Amgen Research (Munich) GmbH 25
Testing effectiveness (Phase 2)Looking for participantsNCT06367075What this trial is testingA Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue SarcomaWho this might be right forAdvanced Soft-tissue Sarcoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Early research (Phase 1)Active Not RecruitingNCT06723964What this trial is testingAP505 Injection in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Solid Tumors AP Biosciences Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT06834399What this trial is testingTATE and KN046 in MCRCWho this might be right forColorectal Cancer with Hepatic Metastases Zhejiang Raygene Pharmaceuticals Co., Ltd 42
Early research (Phase 1)Study completedNCT00244946What this trial is testingCombination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute 15
Post-approval studies (Phase 4)Looking for participantsNCT06057402What this trial is testingElranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Pfizer 80
Testing effectiveness (Phase 2)Looking for participantsNCT06186648What this trial is testingEvaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter SyndromeWho this might be right forRichter Syndrome French Innovative Leukemia Organisation 40
Early research (Phase 1)Active Not RecruitingNCT04077463What this trial is testingLazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Janssen Research & Development, LLC 701
Early research (Phase 1)Study completedNCT03912441What this trial is testingFirst-In-Human Study to Evaluate Safety And Pharmacokinetics of Single Escalating Doses of BCD-147 (Bispecific Anti-HER2/HER2 Antibody) in Healthy SubjectsWho this might be right forHealthy Biocad 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05663866What this trial is testingPremedication to Reduce Amivantamab Associated Infusion Related ReactionsWho this might be right forCarcinoma, Non-Small-Cell Lung Janssen Research & Development, LLC 68